drugset / Trial / NCT03396393
Exploratory Study of DHA in Systemic Lupus Erythematosus Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of the study is to assess the efficacy of DHA in patients with SLE.
Timeline
- Start
- 2018-03
- Primary completion
- 2021-12
- Completion
- 2022-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARTENIMOL | Small molecule | 40 mg | Oral |
| Subject | ARTENIMOL | Small molecule | 80 mg | Oral |
| Subject | ARTENIMOL | Small molecule | 120 mg | Oral |